Skip to main navigation
  • Home
  • The History of Synthetic Biology
  • Designing Synthetic Biotics
  • Pipeline
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds
explore the
possibilities

Synlogic Therapeutics

Investor Relations

IR menu

  • Overview
  • News
    News Releases In the News
  • Events & Presentations
    Events Presentations
  • Publications
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Corporate Governance
    Governance Highlights Leadership Board of Directors Committee Composition
  • Financials
    SEC Filings Quarterly Results
  • Investor Resources
    FAQs Contact IR Email Alerts RSS Feeds

News

  • Home
  • The History of Synthetic Biology
  • Designing Synthetic Biotics
  • Pipeline
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
  • Investors + Media
    • Company Overview
    • News
      • News Releases
      • In the News
    • Events & Presentations
      • Events
      • Presentations
    • Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
      • Quarterly Results
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds
News Releases
November 12, 2024
Synlogic Reports Third Quarter 2024 Financial Results
August 8, 2024
Synlogic Reports Second Quarter 2024 Financial Results
May 14, 2024
Synlogic Reports First Quarter 2024 Financial Results

View All

In the News
Source
Grow By Ginkgo
Getting Under the Skin
January 9, 2024
Source
CSIMarket
Shifting Landscapes: Synlogic's Potential Expansion of PKU Treatment Trial to Adolescents ?? An Examination of Therapeutic Innovation
January 4, 2024
Source
Gingko Bioworks
Synlogic Leverages Ginkgo’s Cell Engineering Platform to Develop Potential New Treatment for Homocystinuria
October 23, 2023

View All

Investor Resources

  • Contact IR
  • Investor FAQs
  • RSS Feeds

Investor Email Alerts

Synlogic Therapeutics

Contact

Synlogic

PO Box 30
Winchester, MA 01890

info@synlogictx.com
(617) 659-2802

  • Twitter
  • LinkedIn
  • Youtube
  • Facebook
  • Instagram

Privacy and Terms

© 2026 Synlogic
Privacy Policy